Materials And Products Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Everolimus, Atc L04aa18 for the Period February 1St, 2024 - January 31St, 2...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Betahistin, Atc N07ca01 for the Period February 1St, 2024 - January 31St, 2...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Amlodipine Hct Ramipril, Atc C09bx03 for the Period February 1St, 2024 - Ja...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Prednisolone, Atc S01ba04 for the Period February 1St, 2024 - January 31St,...

Finished Medicine Orylmyte (Atc: V01aa03 - House Dust Mites)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Follitropin Alfa, Atc G03ga05 for the Period February 1St, 2024 - January 3...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Brimonidine Timolol, Atc S01ed69 for the Period February 1, 2024 - January...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), with the Exception o...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Flecainide (Atc Code: C01bc04).

Completion of a Non-Exclusive Discount Contract According to Section 130A Paragraph 8 or 130C Paragraph 1 Sgb V for Lebrikizumab, Atc Code: D11ah10 for the Period from January 1St, 2024 to December 31...